BioCentury
ARTICLE | Financial News

Bonti raises $15.5M in series C

February 2, 2018 8:27 PM UTC

Botulinum neurotoxin play Bonti Inc. (Newport Beach, Calif.) raised $15.5 million on Jan. 23 in a series C round led by existing investor City Hill Ventures. Other undisclosed new and existing investors participated...

BCIQ Company Profiles

Bonti Inc.